Miyamoto Yoshiaki, Iegaki Noriyuki, Fu Kequan, Ishikawa Yudai, Sumi Kazuyuki, Azuma Sota, Uno Kyosuke, Muramatsu Shin-Ichi, Nitta Atsumi
Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
Division of Neurology, Jichi Medical University, Shimotsuke, Japan.
Int J Neuropsychopharmacol. 2017 Dec 1;20(12):1027-1035. doi: 10.1093/ijnp/pyx078.
Several clinical studies have suggested that N-acetylaspartate and N-acetylaspartylglutamate levels in the human brain are associated with various psychiatric disorders, including major depressive disorder. We have previously identified Shati/Nat8l, an N-acetyltransferase, in the brain using an animal model of psychosis. Shati/Nat8l synthesizes N-acetylaspartate from L-aspartate and acetyl-coenzyme A. Further, N-acetylaspartate is converted into N-acetylaspartylglutamate, a neurotransmitter for metabotropic glutamate receptor 3.
Because Shati/Nat8l mRNA levels were increased in the dorsal striatum of mice following the exposure to forced swimming stress, Shati/Nat8l was overexpressed in mice by the microinjection of adeno-associated virus vectors containing Shati/Nat8l gene into the dorsal striatum (dS-Shati/Nat8l mice). The dS-Shati/Nat8l mice were further assessed using behavioral and neurochemical tests.
The dS-Shati/Nat8l mice exhibited behavioral despair in the forced swimming and tail suspension tests and social withdrawal in the 3-chamber social interaction test. These depression-like behaviors were attenuated by the administration of a metabotropic glutamate receptor 2/3 antagonist and a selective serotonin reuptake inhibitor. Furthermore, the metabolism of N-acetylaspartate to N-acetylaspartylglutamate was decreased in the dorsal striatum of the dS-Shati/Nat8l mice. This finding corresponded with the increased expression of glutamate carboxypeptidase II, an enzyme that metabolizes N-acetylaspartylglutamate present in the extracellular space. Extracellular serotonin levels were lower in the dorsal striatum of the dS-Shati/Nat8l and normal mice that were repeatedly administered a selective glutamate carboxypeptidase II inhibitor.
Our findings indicate that the striatal expression of N-acetylaspartate synthetase Shati/Nat8l plays a role in major depressive disorder via the metabotropic glutamate receptor 3-mediated functional control of the serotonergic neuronal system.
多项临床研究表明,人脑中的N-乙酰天门冬氨酸和N-乙酰天门冬氨酰谷氨酸水平与包括重度抑郁症在内的多种精神疾病相关。我们之前利用精神病动物模型在脑中鉴定出一种N-乙酰基转移酶Shati/Nat8l。Shati/Nat8l可利用L-天门冬氨酸和乙酰辅酶A合成N-乙酰天门冬氨酸。此外,N-乙酰天门冬氨酸可转化为N-乙酰天门冬氨酰谷氨酸,这是一种代谢型谷氨酸受体3的神经递质。
由于暴露于强迫游泳应激后小鼠背侧纹状体中Shati/Nat8l mRNA水平升高,通过向背侧纹状体显微注射含Shati/Nat8l基因的腺相关病毒载体使Shati/Nat8l在小鼠中过表达(dS-Shati/Nat8l小鼠)。使用行为和神经化学测试对dS-Shati/Nat8l小鼠进行进一步评估。
dS-Shati/Nat8l小鼠在强迫游泳和悬尾试验中表现出行为绝望,在三室社交互动试验中表现出社交退缩。代谢型谷氨酸受体2/3拮抗剂和选择性5-羟色胺再摄取抑制剂的给药可减轻这些类似抑郁的行为。此外,dS-Shati/Nat8l小鼠背侧纹状体中N-乙酰天门冬氨酸向N-乙酰天门冬氨酰谷氨酸的代谢减少。这一发现与谷氨酸羧肽酶II表达增加一致,谷氨酸羧肽酶II是一种代谢细胞外空间中N-乙酰天门冬氨酰谷氨酸的酶。重复给予选择性谷氨酸羧肽酶II抑制剂后,dS-Shati/Nat8l小鼠和正常小鼠背侧纹状体中的细胞外5-羟色胺水平较低。
我们的研究结果表明,N-乙酰天门冬氨酸合成酶Shati/Nat8l在纹状体中的表达通过代谢型谷氨酸受体3介导的5-羟色胺能神经系统功能控制在重度抑郁症中起作用。